• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov12
Inovio Pharmaceuticals Set to Raise About $26.5 Million Through Public Offering of 13.158 Million Shares
12:17
Nov11
Inovio Pharma released FY2025 Q3 earnings on November 10 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.8721 (forecast USD -0.4233)
00:00
Inovio Pharma released FY2025 9 Months Earnings on November 10 After-Market EST, Actual Revenue: USD 65.34K, Actual EPS: USD -1.1157
00:00
Nov3
INOVIO Completes Rolling Submission for INO-3107 Biologics License Application
13:06
Inovio Pharma to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast EPS -0.4233 USD
00:16
Sep25
INOVIO to Present INO-3107 Data and Next-Generation DNA Drug Technologies at Upcoming Scientific Conferences
12:06

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -45.5 M, EPS -0.8721

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -23.52 M, EPS -0.6057

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 65.34 K, Net Income -19.69 M, EPS -0.51

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
GURE
8.190
+72.78%
+3.450
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
View More